Pancreatic Cancer Research

ResearcherKoç UniversityActive in the last 2 years

Selahattin Can Özcan

ORCID-verified (high confidence)As of 13 November 2026

Matched on ORCID iD 0000-0003-1733-4288; OpenAlex author ID A5000576827.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
2 (first author 2, last author 0)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Collaborators
2
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. Stress adaptation pathways and HA-CD44 signaling maintain the survival of pancreatic cancer cells with centrosome amplification. First author DOI 10.1186/s12964-026-02865-5↗
  2. PFKFB2 regulates glycolysis and proliferation in pancreatic cancer cells. First author DOI 10.1007/s11010-020-03751-5↗

Closest collaborators

The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Ceyda Açılan Ayhan · 1 shared paper, 2026
  2. Abdullah Yalçın · 1 shared paper, 2020

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.